Abstract
Traditionally cardioverter-defibrillator implantation was performed by surgeons under general anesthesia. However, with advances in lead and pulse generator technology, the surgical implantation technique has been simplified and routine pectoral pulse generator placement without general anesthesia is now possible. To assess the economic benefit of pectoral implantation, we analyzed 43 consecutive initial transvenous defibrillator implantations. The patients were grouped according to whether the implant was abdominal by a surgeon in the operating room (n = 23) or pectoral by an electrophysiologist in a laboratory (n = 20). The duration of hospitalization was significantly longer in the operating room than in the laboratory group (8.1 ± 3.4 vs 5.8 ± 2.4 days, p = 0.01), which was due primarily to the postoperative stay which averaged 1.9 days longer. Total costs were $40,274 ± 6,861 for the operating room cohort and $32,546 ± 3,634 for the lab group (p < 0.001). This reduction was due to a 32% lowering of professional costs and an 18% lowering of facility costs. We conclude that pectoral defibrillator implantation is cost effective and results in significant reductions of hospital stay.
Similar content being viewed by others
References
Saksena S, Parsonnet V. Implantation of a cardioverter/ defibrillator without thoracotomy using a triple-electrode system. JAMA 1988;259:69-72.
Bardy GH, Allen MD, Mehra R, Johnson G. An effective and adaptable transvenous defibrillation system for use in humans. J Am Coll Cardiol 1990;16:887-895.
McCowan R, Maloney J, Wilkoff B, et al. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. J Am Coll Cardiol 1991;17:415-421.
Yee R, Klein GJ, Leitch JW, et al. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator: Nonthoracotomy approach to implantation. Circulation 1992;85:196-204.
Trappe H-J, Klein H, Fieguth H-G, Kielblock B, Wenzlaff P, Lichtlen PR. Initial experience with a new transvenous defibrillation system. PACE 1993;16:134-140.
Block M, Hammel D, Bocker D, et al. A prospective randomized cross-over comparison of mono-and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994;5:581-590.
Natale A, Sra J, Axtell K, et al. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with standard monophasic device using the same lead system. J Am Coll Cardiol 1994; 24:406-412.
Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304-310.
Wyse DG, Kavanagh KM, Gillis AM, et al. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71:197-202.
Shorofsky SR, Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol 1996;78:313-316.
Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996;78:540-543.
Gold MR, Shorofsky SR. Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol 1996;7:570-580.
Strickberger SA, Hummel JD, Daoud E, et al. Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 1994;90:868-872.
Fitzpatrick AP, Lesh MD, Epstein LM, et al. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 1994;89:2503-2508.
Tung RT, Bajaj AK. Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol 1995;75:908-912.
Strickberger SA, Niebauer M, Man KC, et al. Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory. Am J Cardiol 1995;75:225-257.
Trappe H-J, Pfitzner P, Heintze J, et al. Cardioverter-defibrillator implantation in the catherization laboratory: Initial experiences in 48 patients.AmHeart J 1995;29:259-264.
Pacifico A, Wheelan KR, Nasir N, et al. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation 1997; 95:946-950.
Williamson BD, Man KC, Niebauer M, et al. The economic impact of transvenous defibrillation lead systems. PACE 1994;17:2297-2303.
Venditti FJ, O'Connell M, Martin DT, Shahian DM. Transvenous cardioverter defibrillators: Cost implications of a less invasive approach. PACE 1995;18:711-715.
Moss AJ, Hall J, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
Saksena S, for the PCD Investigators. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE 1993;16: 202-207.
Kleman JM, Castle LW, Kidwell GA, et al. Nonthoracotomy-versus thoracotomy-implantable defibrillators. Intention-to-treat comparison of clinical outcomes. Circulation 1994;90: 2833-2842.
Zipes DP, Roberts D. Results of the international study of implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
Ong JLC, Hsu PC, Lin L, et al. Arrhythmias after cardioverter-defibrillator implantation: Comparison of epicardial and transvenous systems. Am J Cardiol 1995;75:137-140.
Raitt MH, Johnson G, Dolack GL, Poole JE, Kudenchuk PJ, Bardy GH. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol 1995;25:1576-1583.
Gold MR, Khalighi K, Kavesh NG, Daly B, Peters RW, Shorofsky SR. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997;79:1623-1627.
Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996;28:1278-1282.
Stamato NJ, O'Toole MF, Enger EL. Permanent pacemaker implantation in the cardiac catheterization laboratory versus the operating room: An analysis of hospital charges and complications. PACE 1992;15:2236-2239.
The Antiarrhythmic Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug threapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gold, M.R., Froman, D., Kavesh, N.G. et al. A Comparison of Pectoral and Abdominal Transvenous Defibrillator Implantation: Analysis of Costs and Outcomes. J Interv Card Electrophysiol 2, 345–349 (1998). https://doi.org/10.1023/A:1009756520054
Issue Date:
DOI: https://doi.org/10.1023/A:1009756520054